ENLITIC, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.35 AUD | -12.50% |
|
-27.08% | -59.30% |
| Sales 2024 * | 6.4M 9.6M 504M | Sales 2025 * | 17.7M 26.56M 1.39B | Capitalization | 20.16M 30.26M 1.59B |
|---|---|---|---|---|---|
| Net income 2024 * | -9M -13.51M -708M | Net income 2025 * | - 0 0 | EV / Sales 2024 * | 6.7 x |
| Net Debt 2024 * | 22.7M 34.07M 1.79B | Net Debt 2025 * | 21.8M 32.71M 1.72B | EV / Sales 2025 * | 2.37 x |
| P/E ratio 2024 * |
-2.33
x | P/E ratio 2025 * |
-
| Employees | - |
| Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99% |
More Fundamentals
* Assessed data
More news
| 1 day | -12.50% | ||
| 1 week | -27.08% | ||
| Current month | -41.67% | ||
| 1 month | -41.67% | ||
| 3 months | -50.35% | ||
| Current year | -59.30% |
1 week
0.35
0.45
1 month
0.350.59
Current year
0.351.01
1 year
0.351.01
3 years
0.351.01
5 years
0.351.01
10 years
0.351.01
| Managers | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 49 | 31/05/23 | |
Darrell Trump
COO | Chief Operating Officer | - | - |
Steve Rankin
PRN | Corporate Officer/Principal | - | 01-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 49 | 31/05/23 | |
Lawrence Gozlan
CHM | Chairman | 45 | - |
Riichi Yamada
BRD | Director/Board Member | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 21/05/24 | 0.35 | -12.50% | 42 133 |
| 20/05/24 | 0.4 | 0.00% | 18,589 |
| 16/05/24 | 0.4 | -9.09% | 2,500 |
| 15/05/24 | 0.44 | -8.33% | 2,410 |
Delayed Quote Australian S.E., May 21, 2024 at 07:10 am
More quotes
Enlitic, Inc. is a healthcare information technology (IT) company that uses Artificial Intelligence (AI) in applications to address issues plaguing the delivery of healthcare. Enlitic Curie is the Company's foundational platform that uses AI to unlock the value of the customer's data in real time. ENDEX, the Company's software application powered by the Curie platform, improves every aspect of workflow for radiologists. ENDEX conforms health system data to consistent clinical standards, enables relevant linkage across different care systems, uses AI to create hanging protocol displays, improves image routing and orchestration, and automatically standardizes DICOM descriptions before transmission to PACS. The Company's product consists of standarization, anonymization, and real-world evidence (RWE) database.
Sector
IT Services & Consulting
Trading Rating
Investor Rating
ESG Refinitiv
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -59.30% | 23.07M | |
| +18.89% | 3.86B | |
| +2.59% | 3.16B | |
| -33.04% | 1.67B | |
| -25.30% | 629M | |
| -12.88% | 343M | |
| -26.07% | 310M | |
| -10.90% | 213M | |
| -0.78% | 207M | |
| -19.35% | 143M |
- Stock Market
- Equities
- ENL Stock
